Skip to main content

Table 2 Prevalence and incidence density rates of multidrug-resistant organisms (MDRO) in 8 Chinese intensive care units (ICU) for the 686 patients

From: First multicenter study on multidrug resistant bacteria carriage in Chinese ICUs

Indicator

All MDRO

MRSA

ESBL-E

A. baumannii

P. aeruginosa

Number of imported cases

247

22

224

9

4

Number of ICU-acquired cases

104

36

69

35

5

Prevalence rate on admission (n/100 admissions)

36.0 

3.2 %

32.7 %

1.3 %

0.6 %

Prevalence rate on discharge (n/100 admissions)

51.2 %

8.5 %

42.7 %

6.4 %

1.3 %

Global prevalence density rate (n/1000 hospital-days)

71.1 ‰

11.7 ‰

59.3 ‰

8.9 ‰

1.8 ‰

Incidence density rate (n/1000 hospital-days)

35.0 ‰

7.5 ‰

21.5 ‰

7.3 ‰

1.0 ‰

Attack rate (n/100 admissions)

- overall

23.7 %

5.1 %

14.9 %

5.2 %

0.7 %

- ICU stay ≤ 1 week

13.2 %

2.1 %

9.4 %

1.8 %

0

- 1 week < ICU stay ≤ 2 weeks

40.3 %

11.5 %

26.2 %

12.2 %

0

- 2 weeks < ICU stay ≤ 3 weeks

56.5 %

19.5 %

21.4 %

15.9 %

0

- ICU stay > 3 weeks

82.1 %

13.7 %

46.7 %

11.8 %

9.6 %

  1. MRSA methicillin-resistant Staphylococcus aureus, ESBL-E Enterobacteriaceae producing extended-spectrum beta-lactamase